Utilizing Gene Therapy to Induce Long-Term Treatment of Wet AMD & Diabetic Retinopathy

Time: 9:55 am
day: Day One

Details:

  • Outline the RGX-314 gene therapy program
  • Discussing why suprachoroidal/subretinal delivery are optimal for this treatment
  • Reviewing the current clinical data from Phase III clinical trials

Speakers: